Clinical Outcomes and Follow-Up Care in Gynecological Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 5865
Special Issue Editors
Interests: gynecological cancer survivorship and follow-up
Special Issue Information
Dear Colleagues,
Over the past decade, there has been increasing focus on cancer survivorship and the impact that this may have on patient outcomes. The incidence of gynaecological cancers is changing in many countries and as a result many changes have been proposed for patient follow-up, with a greater emphasis on tailoring follow-up schemes and schedules to patients’ needs. The COVID-19 pandemic accelerated the introduction of virtual follow-up schemes in many countries, for example, telephone or patient-initiated follow-up. Clinical trials to date have mainly focused on the role of such schemes in uterine cancer, although the impact on long-term survival has yet to be determined. In this Special Issue on ‘Clinical Outcomes and Follow-Up Care in Gynecological Cancers’, we aim to cover all aspects of gynaecological cancer follow-up, including patient experiences, clinical outcomes and the impact on healthcare providers. We welcome articles from research to clinical applications.
Dr. Esther Louise Moss
Dr. Jo Morrison
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cervical cancer
- ovarian cancer
- uterine cancer
- survivorship
- quality of life
- patient-initiated follow-up
- personalised stratified follow-up
- late effects
- patient experience
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
